Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally
Macro·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.
Eli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share.”
Bloomberg — Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally